HOME / ¹®¼­°øÀ¯ / /

ÀÇ´ë º»°ú 4Çгâ PK °úÁ¦(ÈíÀÔ±â Á¾·ù GINAHDAC2) - ½æ³×ÀÏ 1page
1/3
  • 1 page
  • 2 page
  • 3 page

ÀÇ´ë º»°ú 4Çгâ PK °úÁ¦(ÈíÀÔ±â Á¾·ù GINAHDAC2)

¼­½Ä¹øÈ£
TZ-SHR-885521
µî·ÏÀÏÀÚ
2018.05.03
ºÐ·®
3 page / 113.5 KB
Æ÷ÀÎÆ®
700 Point ¹®¼­°øÀ¯ Æ÷ÀÎÆ® Àû¸³¹æ¹ý ¾È³»
ÆÄÀÏ Æ÷¸Ë
ÇѱÛ(hwp)
Èıâ Æò°¡

0

0°ÇÀÇ Èı⺸±â

µî·ÏÀÚ

pa**** ºê·ÐÁî

µî±Þº° ÇýÅú¸±â

ÀÇ´ë º»°ú 4Çгâ PK °úÁ¦(ÈíÀÔ±â Á¾·ù GINAHDAC2)¿¡ ´ëÇØ ±â¼úÇÑ ¸®Æ÷Æ® Âü°íÀÚ·áÀÔ´Ï´Ù.

  • ÇѱÛ(hwp)ÇѱÛ(hwp)
PKÇг⺻°úÁ¾·ùÀÇ´ëÈíÀÔ±âGINAHDAC°úÁ¦
¿¬°ü ÃßõÀÚ·á

1Àå ÈíÀÔ±â Á¾·ù

2Àå GINA

3Àå Histone deacetylase-2(HDAC2)

1.ÈíÀÔ±â Á¾·ù
(1) ³×ºä¶óÀÌÁ®
(2) °¡¾Ð Á¤·®ºÐ¹«½Ä ÈíÀÔ±â(mdi)
: °¡¾Ð ±Ý¼Ó Åë¿¡ °í¾Ð °¡½ºÀÇ ÃßÁøü¿Í ¾àÁ¦ÀÇ È¥ÇÕ¹°ÀÌ ´ã°ÜÁ® ÀÖÀ½.ÀÌ È¥ÇÕ¾×À» Èçµé¾î ÅëÀ» ´©¸£¸é valve-systemÀ» ÅëÇØ ÀÏÁ¤·®ÀÌ ºÐÃâµÇ°Ô µÊ.

-»ç¿ë¹ý : ÈíÀÔ±âÀÇ ¶Ñ²±À» ¿­°í ÈíÀԱ⸦ Áã°í 3~4ȸ Èçµì´Ï´Ù. õõÈ÷ ¼ûÀ» ³¡±îÁö ³»½® ÈÄ ¸ñÀ» ¾à°£ µÚ·Î Á¥Èù µÚ ÀÔÀ» Å©°Ô ¹ú¸®°í ÈíÀԱ⸦ ÀÔ¿¡¼­ 3cm Á¤µµ ¶³¾îÁö°Ô À§Ä¡½ÃÅ°°í ¾öÁö ¼Õ°¡¶ô°ú °¡¿îµ¥ ¼Õ°¡¶ôÀ» ¼¼°Ô ´©¸£´Â µ¿½Ã¿¡ õõÈ÷ ³¡±îÁö ¼ûÀ» µéÀÌ ¸¶½Ê´Ï´Ù

ÀÌ ¶§ ºÐ»çµÈ ¾àÁ¦°¡ ¸ðµÎ Æó ¼ÓÀ¸·Î µé¾î°¡°Ô ÇÕ´Ï´Ù. ÈíÀԱ⸦ ÀÔ¿¡¼­ ¶¼°í ¾à 10ÃÊ µ¿¾È ¼ûÀ» ¸ØÃß¾ú´Ù°¡ õõÈ÷ ³»½±´Ï´Ù

-ÈíÀÔ Ä¡·á½Ã ÀÛµ¿°ú È£ÈíÀ» ÀÏÄ¡½ÃÄÑ¾ß ÇÏ´Â »ç¿ë»óÀÇ ±â¼úÀÌ ÇÊ¿äÇÏ¸ç ¾î·Á¿òÀ» ´À³¢´Â ȯÀÚÀÇ °æ¿ì À̸¦ º¸¿ÏÇϱâ À§ÇØ spacer¸¦ »ç¿ëÇϱ⵵ ÇÑ´Ù.
(3) °ÇÁ¶ ºÐ¸» ÈíÀÔ±â(dpi)
: Á¤ÇØÁø ¾àÀÇ ¾àÁ¦°¡ ºÐ¸» ÇüÅ·Πĸ½¶À̳ª µð½ºÅ© À§¿¡ ÀÛÀº ¼ÒÆ÷¿¡ ÀúÀåµÇ¾î ÀÖ´Ù°¡ ÈíÀÔÇϱâ Àü¿¡ ºÐ¸»ÀÌ ÈíÀԱ⿡ ÀåÀüµÇ°í À̸¦ ȯÀÚ°¡ ÈíÀÔÇÏ°Ô µÇ´Â ÀåÄ¡.¿øÆÇ ÈíÀÔ±â ¹× Åͺ¸ ÈíÀԱⰡ ÀÖ´Ù.

-¿øÆÇ ÈíÀԱ⠻ç¿ë¹ý : ¿Þ¼ÕÀ¸·Î µð½ºÄ¿½ºÀÇ ¶Ñ²±À» Àâ°í ¿À¸¥¼Õ ¾öÁö¼Õ°¡¶ôÀ» Ȩ¿¡ ³¢¿î ÈÄ ¡®µü¡¯ ¼Ò¸®°¡ ³¯ ¶§±îÁö µ¹¸³´Ï´Ù. ÀÛµ¿·¹¹ö¸¦ ¡®µü¡¯ ¼Ò¸®°¡ ³¯ ¶§±îÁö µ¹¸³´Ï´Ù

°í°³¸¦ ¿·À¸·Î µ¹·Á ¼ûÀ» ³»½® ÈÄ ÀÔ±¸¿¡ ÀÔÀ» ´ë°í ºü¸£°í ±í°Ô ÈíÀÔÇÕ´Ï´Ù. 10ÃÊ µ¿¾È ¼ûÀ» ¸ØÃß¾ú´Ù°¡ õõÈ÷ ³»½±´Ï´Ù

¶Ñ²±À» ´Ý½À´Ï´Ù.
¹°·Î ÀÔ¾ÈÀ» Ç󱸾î³À´Ï´Ù.

-Åͺ¸ ÈíÀԱ⠻ç¿ë¹ý : ¶Ñ²±À» µ¹·Á ¿±´Ï´Ù. ¿Þ¼ÕÀº ÅͺÎÇï·¯ÀÇ ¸öü¸¦ ¶È¹Ù·Î ¼¼¿î »óÅ·ΠÀâ°í ¿À¸¥¼ÕÀº »ö±òÀÌ ÀÖ´Â ¹Ù´Ú ºÎºÐÀ» Àâ¾Æ ¿À¸¥ÂÊÀ¸·Î ³¡±îÁö µ¹·È´Ù°¡ ´Ù½Ã ¿ÞÂÊÀ¸·Î ¡®µü¡¯ ¼Ò¸®°¡ ³¯ ¶§±îÁö µ¹¸³´Ï´Ù

ÅͺÎÇï·¯ÀÇ ÈíÀÔ±¸¸¦ ÇÇÇØ ¼ûÀ» ³¡±îÁö ³»½±´Ï´Ù. ÅͺÎÇï·¯ÀÇ ÈíÀÔ±¸¸¦ ÀÔ¿¡ ¹°°í ºü¸£°í ±íÀÌ ¼ûÀ» µéÀ̸¶½Ê´Ï´Ù

10ÃÊ µ¿¾È ¼ûÀ» ¸ØÃß¾ú´Ù°¡ õõÈ÷ ³»½±´Ï´Ù.
2.gina
the global initiative for asthma (gina) works with health care professionals and public health officials around the world to reduce asthma prevalence, morbidity, and mortality.through resources such as evidence-based guidelines for asthma management, and events such as the annual celebration of world asthma day, gina is working to improve the lives of people with asthma in every corner of the globe.
gina was launched in 1993 in collaboration with the national heart, lung, and blood institute, national institutes of health, usa, and the world health organization.ginas program is determined and its guidelines for asthma care are shaped by committees made up of leading asthma experts from around the world.
gina objectives  
-increase awareness of asthma and its public health consequences.   (ÀÌÇÏ »ý·«)

¹ÞÀº º°Á¡

0/5

0°³ÀÇ º°Á¡

¹®¼­°øÀ¯ ÀڷḦ µî·ÏÇØ ÁÖ¼¼¿ä.
¹®¼­°øÀ¯ Æ÷ÀÎÆ®¿Í Çö±ÝÀ» µå¸³´Ï´Ù.

Æ÷ÀÎÆ® : ÀÚ·á 1°Ç´ç ÃÖ´ë 5,000P Áö±Þ

Çö±Ý : ÀÚ·á 1°Ç´ç ÃÖ´ë 2,000¿ø Áö±Þ

ÈıâÀÛ¼º»ç¿ëÈı⸦ ÀÛ¼ºÇÏ½Ã¸é ¹®¼­°øÀ¯ 100 point¸¦ Àû¸³ÇØ µå¸³´Ï´Ù.

¼­½Äº°Á¡ ¡Ù¡Ù¡Ù¡Ù¡Ù

0/120

»ç¿ëÈıâ (0)

µî·ÏµÈ ¸®ºä°¡ ¾ø½À´Ï´Ù.

ù¹ø° ¸®ºä¾î°¡ µÇ¾îÁÖ¼¼¿ä.

ÀÌÀü1´ÙÀ½